270 related articles for article (PubMed ID: 30504333)
1. Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy.
Porter J
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):361-370. PubMed ID: 30504333
[TBL] [Abstract][Full Text] [Related]
2. Decision-making about gene therapy in transfusion dependent thalassemia.
Quarmyne MO; Ross D; Sinha C; Bakshi N; Boudreaux J; Krishnamurti L
BMC Pediatr; 2022 Sep; 22(1):536. PubMed ID: 36085025
[TBL] [Abstract][Full Text] [Related]
3. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia.
Thuret I; Ruggeri A; Angelucci E; Chabannon C
Stem Cells Transl Med; 2022 Apr; 11(4):407-414. PubMed ID: 35267028
[TBL] [Abstract][Full Text] [Related]
4. Thalassemia Major: Transplantation or Transfusion and Chelation.
Mohamed SY
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
Shenoy S; Thompson AA
Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life with standard and curative therapies in thalassemia: A narrative literature review.
Shah R; Badawy SM
Ann N Y Acad Sci; 2024 Feb; 1532(1):50-62. PubMed ID: 38270933
[TBL] [Abstract][Full Text] [Related]
7. Health state utilities associated with treatment for transfusion-dependent β-thalassemia.
Matza LS; Paramore LC; Stewart KD; Karn H; Jobanputra M; Dietz AC
Eur J Health Econ; 2020 Apr; 21(3):397-407. PubMed ID: 31828456
[TBL] [Abstract][Full Text] [Related]
8. Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies.
Taher AT; Bou-Fakhredin R; Kattamis A; Viprakasit V; Cappellini MD
Expert Rev Hematol; 2021 Oct; 14(10):897-909. PubMed ID: 34493145
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for thalassemia.
Elborai Y; Uwumugambi A; Lehmann L
Immunotherapy; 2012 Sep; 4(9):947-56. PubMed ID: 23046238
[TBL] [Abstract][Full Text] [Related]
10. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
Fitzhugh CD; Abraham A; Hsieh MM
Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
[TBL] [Abstract][Full Text] [Related]
11. Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing.
Corbacioglu S; Frangoul H; Locatelli F; Hobbs W; Walters M
Am J Hematol; 2024 Mar; 99(3):422-429. PubMed ID: 38100154
[TBL] [Abstract][Full Text] [Related]
12. Transition of Care for Patients with Thalassemia.
Chandra J; Sahi PK
Indian J Pediatr; 2023 Dec; 90(12):1227-1231. PubMed ID: 37133752
[TBL] [Abstract][Full Text] [Related]
13. β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.
Langer AL; Esrick EB
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):600-606. PubMed ID: 34889443
[TBL] [Abstract][Full Text] [Related]
14. New updating into hemoglobinopathies.
Fucharoen S; Winichagoon P
Int J Lab Hematol; 2012 Dec; 34(6):559-65. PubMed ID: 22762348
[TBL] [Abstract][Full Text] [Related]
15. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
Sii-Felice K; Giorgi M; Leboulch P; Payen E
Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Stem Cell Transplantation in Thalassemia.
Strocchio L; Locatelli F
Hematol Oncol Clin North Am; 2018 Apr; 32(2):317-328. PubMed ID: 29458734
[TBL] [Abstract][Full Text] [Related]
18. Recent trends in treatment of thalassemia.
El-Beshlawy A; El-Ghamrawy M
Blood Cells Mol Dis; 2019 May; 76():53-58. PubMed ID: 30792169
[TBL] [Abstract][Full Text] [Related]
19. Thalassemia: a look to the future.
Nathan DG
Ann N Y Acad Sci; 2016 Mar; 1368(1):11-5. PubMed ID: 26866425
[TBL] [Abstract][Full Text] [Related]
20. Investigational drugs in phase I and phase II clinical trials for thalassemia.
Motta I; Scaramellini N; Cappellini MD
Expert Opin Investig Drugs; 2017 Jul; 26(7):793-802. PubMed ID: 28540737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
